DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION

The development and progression of heart failure is associated with a variety of pathophysiological mechanisms, of particular interest is the study of the inflammatory response as a fundamental link in the pathogenesis of CHF and its main component – decompensation. An open, non-randomized, prospect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: O. N. Ogurkova, E. V. Kruchinkina, A. M. Gusakova, T. E. Suslova, V. V. Ryabov
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2021
Materias:
Acceso en línea:https://doaj.org/article/4c6d8929b09b4552b4d156533cf9297c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4c6d8929b09b4552b4d156533cf9297c
record_format dspace
spelling oai:doaj.org-article:4c6d8929b09b4552b4d156533cf9297c2021-11-18T08:03:51ZDYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION1563-06252313-741X10.15789/1563-0625-DCI-2280https://doaj.org/article/4c6d8929b09b4552b4d156533cf9297c2021-10-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/2427https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XThe development and progression of heart failure is associated with a variety of pathophysiological mechanisms, of particular interest is the study of the inflammatory response as a fundamental link in the pathogenesis of CHF and its main component – decompensation. An open, non-randomized, prospective study was carried out to evaluate the clinical and morphological features of subclinical inflammation in patients with acute decompensation of ischemic chronic heart failure with a reduced ejection fraction. The study included 25 patients with decompensated ischemic CHF with left ventricular ejection fraction < 40% aged 35 to 75 years (60.12±9.3 y. o.). In this study the dynamics of the serum content of C-reactive protein (CRP), N-terminal fragment of the brain natriuretic peptide precursor protein (NT-proBNP), soluble ST2(sST2), insulin-like growth factor-1 receptor (IGF-1R), interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor-α (TNFα) was performed by multiplex immunoassay using the FLEXMAP 3D. All studied patients were divided into two groups depending on the diagnosed myocarditis: patients with no signs of myocarditis and patients with myocarditis. It was found that in the group of patients with diagnosed myocarditis there was an increased content of CRP, IGF-1R, IL-6 and IL-10, TNFα compared to the group of patients without myocarditis. The median concentrations of the NT-proBNP and sST2 in both groups did not differ. At the follow-up visit a year later, there was a decrease in the content of CRP, NT-proBNP, IL-6 in both groups. In the group of patients with myocarditis, an increase in the content of sST2, IGF-1R, IL-10 was observed. Thus, the study carried out in dynamics revealed significant differences in the degree of changes in the serum activity of pro- and anti-inflammatory cytokines and biomarkers of cardiovascular risk in patients with decompensated heart failure with systolic dysfunction with diagnosed myocarditis and in its absence.O. N. OgurkovaE. V. KruchinkinaA. M. GusakovaT. E. SuslovaV. V. RyabovSPb RAACIarticleinflammationcytokinesbiomarkersheart failuremyocarditisImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 839-844 (2021)
institution DOAJ
collection DOAJ
language RU
topic inflammation
cytokines
biomarkers
heart failure
myocarditis
Immunologic diseases. Allergy
RC581-607
spellingShingle inflammation
cytokines
biomarkers
heart failure
myocarditis
Immunologic diseases. Allergy
RC581-607
O. N. Ogurkova
E. V. Kruchinkina
A. M. Gusakova
T. E. Suslova
V. V. Ryabov
DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION
description The development and progression of heart failure is associated with a variety of pathophysiological mechanisms, of particular interest is the study of the inflammatory response as a fundamental link in the pathogenesis of CHF and its main component – decompensation. An open, non-randomized, prospective study was carried out to evaluate the clinical and morphological features of subclinical inflammation in patients with acute decompensation of ischemic chronic heart failure with a reduced ejection fraction. The study included 25 patients with decompensated ischemic CHF with left ventricular ejection fraction < 40% aged 35 to 75 years (60.12±9.3 y. o.). In this study the dynamics of the serum content of C-reactive protein (CRP), N-terminal fragment of the brain natriuretic peptide precursor protein (NT-proBNP), soluble ST2(sST2), insulin-like growth factor-1 receptor (IGF-1R), interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor-α (TNFα) was performed by multiplex immunoassay using the FLEXMAP 3D. All studied patients were divided into two groups depending on the diagnosed myocarditis: patients with no signs of myocarditis and patients with myocarditis. It was found that in the group of patients with diagnosed myocarditis there was an increased content of CRP, IGF-1R, IL-6 and IL-10, TNFα compared to the group of patients without myocarditis. The median concentrations of the NT-proBNP and sST2 in both groups did not differ. At the follow-up visit a year later, there was a decrease in the content of CRP, NT-proBNP, IL-6 in both groups. In the group of patients with myocarditis, an increase in the content of sST2, IGF-1R, IL-10 was observed. Thus, the study carried out in dynamics revealed significant differences in the degree of changes in the serum activity of pro- and anti-inflammatory cytokines and biomarkers of cardiovascular risk in patients with decompensated heart failure with systolic dysfunction with diagnosed myocarditis and in its absence.
format article
author O. N. Ogurkova
E. V. Kruchinkina
A. M. Gusakova
T. E. Suslova
V. V. Ryabov
author_facet O. N. Ogurkova
E. V. Kruchinkina
A. M. Gusakova
T. E. Suslova
V. V. Ryabov
author_sort O. N. Ogurkova
title DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION
title_short DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION
title_full DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION
title_fullStr DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION
title_full_unstemmed DYNAMIC CHANGES IN CARDIOVASCULAR RISK BIOMARKERS AND CYTOKINES OF MYOCARDITIS-FREE PATIENTS WITH DECOMPENSATED HEART FAILURE AND ISCHEMIC SYSTOLIC DYSFUNCTION
title_sort dynamic changes in cardiovascular risk biomarkers and cytokines of myocarditis-free patients with decompensated heart failure and ischemic systolic dysfunction
publisher SPb RAACI
publishDate 2021
url https://doaj.org/article/4c6d8929b09b4552b4d156533cf9297c
work_keys_str_mv AT onogurkova dynamicchangesincardiovascularriskbiomarkersandcytokinesofmyocarditisfreepatientswithdecompensatedheartfailureandischemicsystolicdysfunction
AT evkruchinkina dynamicchangesincardiovascularriskbiomarkersandcytokinesofmyocarditisfreepatientswithdecompensatedheartfailureandischemicsystolicdysfunction
AT amgusakova dynamicchangesincardiovascularriskbiomarkersandcytokinesofmyocarditisfreepatientswithdecompensatedheartfailureandischemicsystolicdysfunction
AT tesuslova dynamicchangesincardiovascularriskbiomarkersandcytokinesofmyocarditisfreepatientswithdecompensatedheartfailureandischemicsystolicdysfunction
AT vvryabov dynamicchangesincardiovascularriskbiomarkersandcytokinesofmyocarditisfreepatientswithdecompensatedheartfailureandischemicsystolicdysfunction
_version_ 1718422283876302848